Acesso livre
Acesso livre

Infectologia

M-A | Imunogenicidade, segurança e eficácia das vacinas contra HPV entre pessoas vivendo com HIV.

10 Ago, 2022 | 14:22h

Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis – eClinicalMedicine

 


Antibióticos inalatórios na terapia intensiva: estado da arte e perspectivas futuras.

10 Ago, 2022 | 14:16h

Inhaled antibiotics in critical care: State of the art and future perspectives – Infectious Diseases Now

 


Revisão | Função dos exames de imagens em infecções do sistema nervoso central.

10 Ago, 2022 | 14:14h

Role of imaging in CNS infections – Indian Journal of Pathology & Microbiology

 


Avaliação crítica da evidência atual | Recomendações de dosagem de antibióticos na terapia de substituição renal contínua pediátrica.

9 Ago, 2022 | 16:37h

Antimicrobial Dosing Recommendations in Pediatric Continuous Renal Replacement Therapy: A Critical Appraisal of Current Evidence – Frontiers in Pediatrics

 


Estudo de fase 1 | Anticorpo monoclonal de baixa dose por via subcutânea ou intravenosa pode prevenir malária.

5 Ago, 2022 | 17:45h

Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria – New England Journal of Medicine

Editorial: Monoclonal Antibodies for Malaria – New England Journal of Medicine

 


Estudo randomizado | Seguimento pós-parto de 72 semanas de dolutegravir vs. efavirenz iniciado na gestação.

5 Ago, 2022 | 17:40h

72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study – The Lancet HIV

Conteúdos relacionados:

WHO Recommends Dolutegravir as Preferred HIV Treatment Option in All Populations

Week 96 results from a RCT: Efficacy and safety of dolutegravir or darunavir combined with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection.

RCT: Efficacy and safety of switching to the 2-drug regimen Dolutegravir/Lamivudine vs. continuing a 3- or 4-Drug regimen for maintaining virologic suppression in adults living with HIV-1.

RCT: Low-cost, easy to take antiretroviral treatment based on Dolutegravir as first- or second-Line therapy found to be non-inferior to standard care for treating HIV-1 infection in children.

RCT: Dolutegravir or Darunavir in combination with Zidovudine or Tenofovir to treat HIV.

Randomized controlled trial compared three antiretroviral regimens started in pregnant women with HIV

Randomized Trial: Switching to Dolutegravir/Lamivudine Two-Drug Regimen Noninferior to Continuing a Tenofovir Alafenamide–Based Three- or Four-Drug Regimen for Maintenance of Virologic Suppression in Adults With HIV-1

 


Estudo de caso-controle | Uso ambulatorial de macrolídeo oral está associado com risco aumentado de perda de audição neurossensorial em crianças, adolescentes e jovens adultos.

5 Ago, 2022 | 17:39h

Association of Outpatient Oral Macrolide Use With Sensorineural Hearing Loss in Children, Adolescents, and Young Adults – JAMA Otolaryngology-Head & Neck Surgery (link para o resumo – $ para o texto completo)

Comentário: Kids’ Hearing Loss Associated With Common Antibiotics — Children and teens with sensorineural hearing loss more often macrolide users – MedPage Today (necessário cadastro gratuito)

 


M-A | Eficácia da doxiciclina para pneumonia adquirida na comunidade leve a moderada em adultos.

5 Ago, 2022 | 17:34h

Efficacy of Doxycycline for Mild-to-moderate Community-acquired Pneumonia in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials – Clinical Infectious Diseases (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

 


M-A | Impacto global da dor de garganta e da faringite por estreptococo do grupo A.

5 Ago, 2022 | 17:07h

The global burden of sore throat and group A Streptococcus pharyngitis: A systematic review and meta-analysis – eClinicalMedicine

 


M-A de rede | Resumo das evidências avaliando o ganho de peso corporal entre pessoas em terapia antirretroviral para tratamento de HIV.

5 Ago, 2022 | 17:06h

Evidence synthesis evaluating body weight gain among people treating HIV with antiretroviral therapy – a systematic literature review and network meta-analysis – eClinicalMedicine

 

Comentário no Twitter

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.